Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Annerieke Tavenier"'
Autor:
Enrico Fabris, Abi Selvarajah, Annerieke Tavenier, Rik Hermanides, Elvin Kedhi, Gianfranco Sinagra, Arnoud van’t Hof
Publikováno v:
American Journal of Cardiovascular Drugs. 22:463-474
Antithrombotic therapy is the cornerstone of pharmacological treatment in patients undergoing primary percutaneous coronary intervention (PCI). However, the acute management of ST elevation myocardial infarction (STEMI) patients includes therapy for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4635ef2775518b199e4147c1b3d9799
https://doi.org/10.1007/s40256-022-00531-y
https://doi.org/10.1007/s40256-022-00531-y
Autor:
Mauro Chiarito, Davide Cao, Samantha Sartori, Zhongjie Zhang, Birgit Vogel, Johny Nicholas, Carlo Andrea Pivato, Alessandro Spirito, Annerieke Tavenier, Mark Effron, Giulio G Stefanini, Usman Baber, Samir Kapadia, Sunil Rao, Timothy D Henry, Stuart Pocock, George Dangas, Annapoorna Kini, Roxana Mehran
Publikováno v:
European Heart Journal Supplements. 24
Background Potent P2Y12 inhibitors are recommended in patients with acute coronary syndrome (ACS), although the optimal antithrombotic strategy should be tailored based on patients thrombotic and hemorrhagic risk profile. We evaluated if the benefits
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f84227fa252e8e3f1665a77aafb934fe
https://doi.org/10.1093/eurheartjsupp/suac121.154
https://doi.org/10.1093/eurheartjsupp/suac121.154